Arcus Biosciences Inc.
Organization details
- Legal name
- Arcus Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Hayward
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RCUS
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001724521
- EIN
- 47-3898435
- Wikidata ID
- Q113503877
Board of directors
-
Andrew J. Perlman · DirectorSince 2023
-
Antoni Ribas · DirectorSince 2023
-
David L. Lacey · DirectorSince 2023
-
Dietmar Berger · DirectorSince 2025
- Since 2023
-
Johanna Mercier · DirectorSince 2024
-
Juan C. Jaen · Director · PresidentSince 2023
-
Kathryn E. Falberg · DirectorSince 2023
-
Nicole Lambert · DirectorSince 2023
-
Patrick Machado · DirectorSince 2023
-
Terry J. Rosen · Director · Chief Executive OfficerSince 2023
-
Yasunori Kaneko · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.4%
-
82.4%
-
82.4%
-
88.8%
Board connections
6 of this board's directors also sit on 11 other boards. 10 are in the same sector.
-
Alumis Inc. Same sectorvia Patrick Machado
-
Damora Therapeutics Inc. Same sectorvia Jennifer Jarrett
-
IDEAYA Biosciences Inc. Same sectorvia Terry J. Rosen
-
Neurocrine Biosciences Inc. Same sectorvia Johanna Mercier
-
Nurix Therapeutics Inc. Same sectorvia David L. Lacey
-
Nuvation Bio Inc. Same sectorvia Kathryn E. Falberg
-
Sagimet Biosciences Inc. Same sectorvia Jennifer Jarrett
-
Syndax Pharmaceuticals Inc. Same sectorvia Jennifer Jarrett
- via Kathryn E. Falberg
-
Xenon Pharmaceuticals Inc. Same sectorvia Patrick Machado
-
Zura Bio Limited Same sectorvia Jennifer Jarrett
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $10,472,006
- 35 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Azoy Alexander Officer (Chief Accounting Officer) | Option exercise | +2,827 | $15.44 | $43,649 |
| Aug 21, 2026 | Azoy Alexander Officer (Chief Accounting Officer) | Open-market sale | −2,827 | $30.00 | $84,810 |
| Jul 10, 2026 | Juan C. Jaen Officer (President) | Open-market sale | −19,799 | $28.61 | $566,449 |
| Jul 10, 2026 | Juan C. Jaen Officer (President) | Open-market sale | −268 | $29.40 | $7,879 |
| Jul 9, 2026 | Juan C. Jaen Officer (President) | Open-market sale | −48,502 | $30.05 | $1,457,485 |
| Jun 24, 2026 | Juan C. Jaen Officer (President) | Open-market sale | −6,431 | $29.66 | $190,743 |
| Jun 23, 2026 | Juan C. Jaen Officer (President) | Open-market sale | −14,067 | $27.69 | $389,515 |
| Jun 23, 2026 | Juan C. Jaen Officer (President) | Open-market sale | −1,697 | $28.06 | $47,618 |
| Jun 22, 2026 | Juan C. Jaen Officer (President) | Open-market sale | −9,236 | $27.03 | $249,649 |
| Jun 11, 2026 | Nicole Lambert Director | Grant or award | +5,700 | — | — |
| Jun 11, 2026 | Patrick Machado Director | Grant or award | +5,700 | — | — |
| Jun 11, 2026 | Yasunori Kaneko Director | Grant or award | +5,700 | — | — |
| Jun 11, 2026 | Tang Carolyn C. Officer (General Counsel) | Option exercise | +34,090 | $2.57 | $87,611 |
| Jun 11, 2026 | David L. Lacey Director | Grant or award | +5,700 | — | — |
| Jun 11, 2026 | Kathryn E. Falberg Director | Grant or award | +5,700 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Arcus Biosciences Inc.
Who is the CEO of Arcus Biosciences Inc.?
Terry J. Rosen is Arcus Biosciences Inc.'s Chief Executive Officer.
How many directors are on Arcus Biosciences Inc.'s board?
Arcus Biosciences Inc.'s board has 12 directors: Andrew J. Perlman, Antoni Ribas, David L. Lacey, Dietmar Berger, Jennifer Jarrett, Johanna Mercier, Juan C. Jaen, Kathryn E. Falberg, Nicole Lambert, Patrick Machado and 2 others.
Are Arcus Biosciences Inc. insiders buying or selling shares?
Over the last 12 months, Arcus Biosciences Inc. insiders made no open-market purchases and sold $10.5 million of shares in 35 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="arcus-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.